SIA
WST icon

Sit Investment Associates’s West Pharmaceutical WST Stock Holding History

Sit Investment Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,000
Closed -$1.65M – 556
2019
Q1 		$1.65M Hold
15,000
– – 0.05% 284
2018
Q4 		$1.47M Hold
15,000
– – 0.05% 295
2018
Q3 		$1.85M Sell
15,000
-3,600
-19% -$404K 0.05% 269
2018
Q2 		$1.85M Hold
18,600
– – 0.05% 292
2018
Q1 		$1.64M Hold
18,600
– – 0.04% 307
2017
Q4 		$1.83M Buy
18,600
+9,000
+94% +$882K 0.04% 302
2017
Q3 		$924K Buy
+9,600
New +$869K 0.02% 366

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sit Investment Associates's WST Position: Q2 2019 in Review

Sit Investment Associates sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 15,000 shares — an estimated $1.65M sold.

Sit Investment Associates first reported a position in WST in Q3 2017 and held it in 7 quarters. The position peaked at $1.85M in Q3 2018. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

  • Sit Investment Associates reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • Sit Investment Associates sold 15,000 West Pharmaceutical shares in Q2 2019, an estimated $1.65M.
  • Sit Investment Associates first reported a position in West Pharmaceutical in Q3 2017 and held it in 7 quarters.
  • Sit Investment Associates's West Pharmaceutical position peaked at $1.85M in Q3 2018.
  • 374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on Sit Investment Associates's 13F filing for Q2 2019, filed 14 Aug 2019.